Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1240875
Max Phase: Preclinical
Molecular Formula: C31H38N6O6
Molecular Weight: 590.68
Molecule Type: Small molecule
Associated Items:
ID: ALA1240875
Max Phase: Preclinical
Molecular Formula: C31H38N6O6
Molecular Weight: 590.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)C(=O)NCCCn1ccc(N)nc1=O
Standard InChI: InChI=1S/C31H38N6O6/c1-21(2)18-25(35-31(42)43-20-23-12-7-4-8-13-23)28(39)34-24(19-22-10-5-3-6-11-22)27(38)29(40)33-15-9-16-37-17-14-26(32)36-30(37)41/h3-8,10-14,17,21,24-25H,9,15-16,18-20H2,1-2H3,(H,33,40)(H,34,39)(H,35,42)(H2,32,36,41)/t24?,25-/m0/s1
Standard InChI Key: GMVNISWUDAZZOM-BBMPLOMVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 590.68 | Molecular Weight (Monoisotopic): 590.2853 | AlogP: 1.97 | #Rotatable Bonds: 15 |
Polar Surface Area: 174.51 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.28 | CX Basic pKa: | CX LogP: 2.54 | CX LogD: 2.54 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.15 | Np Likeness Score: -0.39 |
1. Ovat A, Li ZZ, Hampton CY, Asress SA, Fernández FM, Glass JD, Powers JC.. (2010) Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors., 53 (17): [PMID:20690647] [10.1021/jm901221v] |
Source(1):